Case Study: Autologous Adipose Tissue-Derived Mesenchymal Stem Cell Infusion Reduced Symptoms of Atopic Dermatitis
-
By
-
Kosuke Mabuchi
-
Yoshie Takahashi
-
Yuka Okinaka
-
Kana Nagase
-
Yosky Kataoka
-
Akihiko Taguchi
-
May 4, 2026
Clinical Scorecard: Case Study: Autologous Adipose Tissue-Derived Mesenchymal Stem Cell Infusion Reduced Symptoms of Atopic Dermatitis
At a Glance
| Category | Detail |
|---|
| Condition | Atopic Dermatitis |
| Key Mechanisms | Gap junction-mediated reduction of vascular permeability and tissue inflammation. |
| Target Population | Patients with chronic pain and comorbid atopic dermatitis. |
| Care Setting | Clinical setting involving MSC transplantation. |
Key Highlights
- Significant improvement in atopic dermatitis symptoms post-MSC transplantation.
- Asthma attacks ceased following MSC treatment.
- Patient experienced relief from chronic itching and reduced steroid use.
- Increased serum levels of SDF1 and VEGF observed after MSC infusion.
- No recurrence of atopic dermatitis or asthma attacks during follow-up.
Guideline-Based Recommendations
Diagnosis
- Assess atopic dermatitis severity using Eczema Area and Severity Index.
Management
- Consider MSC transplantation for patients with refractory atopic dermatitis.
Monitoring & Follow-up
- Monitor serum levels of SDF1 and VEGF post-treatment.
Risks
- Potential for adverse effects related to MSC transplantation.
Patient & Prescribing Data
32-year-old female with chronic lower back pain and atopic dermatitis.
Autologous MSC transplantation led to significant symptom relief and reduced medication use.
Clinical Best Practices
- Evaluate patient history for exacerbating factors such as alcohol consumption.
- Follow up on symptom resolution and medication usage post-MSC treatment.
Related Resources & Content
